Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ribosomal protein L10 pseudogene (ENSG00000277447) is a processed pseudogene derived from the ribosomal protein L10 gene (RPL10). Pseudogenes are inactive DNA sequences that resemble functional genes but do not produce a functional protein. Human ribosomal protein genes, like RPL10, have many pseudogenes scattered throughout the genome, most of which arose by retrotransposition. These sequences share sequence similarity with their parent gene but are nonfunctional due to mutations such as frame disruptions. Although some pseudogenes can have regulatory roles, there is no evidence that RPL10 pseudogenes—including ENSG00000277447—participate in cellular processes or disease. Thus, it is not considered a molecular drug target, not a receptor, enzyme, transporter, or functional protein
None applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L10 pseudogene (None established; often referred to as RPL10P (with numeric suffixes for individual pseudogenes, e.g. RPL10P1)).